Apotheek Vanheusden: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Apotheek Vanheusden
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€391,389
2024 · €463,062-€71,673
Equity
€294,757
2024 · €293,367+€1,389
Cash
€416,023
2024 · €365,281+€50,742
Balance sheet total
€2.1m
2024 · €2.6m-€504,755
Largest movements
Assets
- Receivables within one year -€530,271
down €530,271 (-35.8%), from €1.5m to €949,328
of which Other amounts receivable: -€503,026
- Cash +€50,742
up €50,742 (+13.9%), from €365,281 to €416,023
mainly Receivables within one year (+€530,271) and Net result for the year (+€391,389)
Equity and liabilities
- Other debts -€418,261
down €418,261 (-23.8%), from €1.8m to €1.3m
- Trade debts -€54,293
down €54,293 (-21.7%), from €250,647 to €196,354
- Debts after one year -€50,000
down €50,000 (-21.4%), from €233,333 to €183,333
Income statement
- Gross operating margin -€42,118
down €42,118 (-6.2%), from €684,380 to €642,262
- Staff costs +€41,615
up €41,615 (+46.8%), from €88,899 to €130,515
- Taxes -€17,811
down €17,811 (-31.2%), from €57,118 to €39,307
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€463,062
Gross operating margin
-€42,118
Staff costs
-€41,615
Depreciation
-€5,164
Other operating charges
+€961
Financial income
-€1,189
Financial charges
-€358
Taxes
+€17,811
Result 2025
€391,389
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€543,513
Investment
-€52,771
Financing
-€440,000
Cash 2024
€365,281
From operations (derived)
+€543,513
Net result for the year
+€391,389
Depreciation
+€71,450
Stocks and contracts
-€3,307
Receivables within one year
+€530,271
Deferred charges and accrued income
+€9,854
Trade debts
-€54,293
Tax, wage and social debts
+€9,115
Other debts
-€418,261
Accrued charges and deferred income
+€7,294
Investment (derived)
-€52,771
Investment in fixed assets (net)
-€52,771
Financing
-€440,000
Debts after one year
-€50,000
Contributions, distributions and other
-€390,000
Cash 2025
€416,023
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,618,391 | €2,113,636 | -€504,755 | -19.3% |
| Fixed assets | 21/28 | €503,803 | €485,125 | -€18,679 | -3.7% |
| Tangible fixed assets | 22/27 | €503,803 | €485,125 | -€18,679 | -3.7% |
| Land and buildings | 22 | €300,351 | €272,278 | -€28,073 | -9.3% |
| Plant, machinery and equipment | 23 | €203,278 | €165,600 | -€37,678 | -18.5% |
| Furniture and vehicles | 24 | €174 | €47,247 | +€47,073 | +27,066% |
| Current assets | 29/58 | €2,114,588 | €1,628,511 | -€486,077 | -23.0% |
| Stocks and contracts in progress | 3 | €230,882 | €234,189 | +€3,307 | +1.4% |
| Stocks | 30/36 | €230,882 | €234,189 | +€3,307 | +1.4% |
| Amounts receivable within one year | 40/41 | €1,479,599 | €949,328 | -€530,271 | -35.8% |
| Trade receivables | 40 | €337,081 | €309,836 | -€27,245 | -8.1% |
| Other amounts receivable | 41 | €1,142,518 | €639,492 | -€503,026 | -44.0% |
| Cash at bank and in hand | 54/58 | €365,281 | €416,023 | +€50,742 | +13.9% |
| Deferred charges and accrued income | 490/1 | €38,826 | €28,971 | -€9,854 | -25.4% |
| Total equity and liabilities | 10/49 | €2,618,391 | €2,113,636 | -€504,755 | -19.3% |
| Equity | 10/15 | €293,367 | €294,757 | +€1,389 | +0.5% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €231,367 | €232,757 | +€1,389 | +0.6% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Distributable reserves | 133 | €225,167 | €226,557 | +€1,389 | +0.6% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €2,325,024 | €1,818,879 | -€506,145 | -21.8% |
| Amounts payable after more than one year | 17 | €233,333 | €183,333 | -€50,000 | -21.4% |
| Financial debts | 170/4 | €233,333 | €183,333 | -€50,000 | -21.4% |
| Amounts payable within one year | 42/48 | €2,089,153 | €1,625,714 | -€463,439 | -22.2% |
| Current portion of amounts payable after more than one year | 42 | €50,000 | €50,000 | = | 0.0% |
| Trade debts | 44 | €250,647 | €196,354 | -€54,293 | -21.7% |
| Suppliers | 440/4 | €250,647 | €196,354 | -€54,293 | -21.7% |
| Taxes, remuneration and social security | 45 | €28,953 | €38,067 | +€9,115 | +31.5% |
| Taxes | 450/3 | €7,175 | €16,423 | +€9,248 | +129% |
| Remuneration and social security | 454/9 | €21,778 | €21,645 | -€133 | -0.6% |
| Other amounts payable | 47/48 | €1,759,553 | €1,341,292 | -€418,261 | -23.8% |
| Accrued charges and deferred income | 492/3 | €2,538 | €9,832 | +€7,294 | +287% |
| Non-recurring operating income | 76A | - | €9,000 | +€9,000 | |
| Remuneration, social security and pensions | 62 | €88,899 | €130,515 | +€41,615 | +46.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €66,285 | €71,450 | +€5,164 | +7.8% |
| Other operating charges | 640/8 | €4,583 | €3,623 | -€961 | -21.0% |
| Gross operating margin | 9900 | €684,380 | €642,262 | -€42,118 | -6.2% |
| Operating profit (loss) | 9901 | €524,612 | €436,675 | -€87,937 | -16.8% |
| Financial income | 75/76B | €2,557 | €1,368 | -€1,189 | -46.5% |
| Recurring financial income | 75 | €2,557 | €1,368 | -€1,189 | -46.5% |
| Financial charges | 65/66B | €6,989 | €7,347 | +€358 | +5.1% |
| Recurring financial charges | 65 | €6,989 | €7,347 | +€358 | +5.1% |
| Profit (loss) for the period before taxes | 9903 | €520,180 | €430,696 | -€89,484 | -17.2% |
| Income taxes | 67/77 | €57,118 | €39,307 | -€17,811 | -31.2% |
| Profit (loss) for the period | 9904 | €463,062 | €391,389 | -€71,673 | -15.5% |
| Profit (loss) for the period to be appropriated | 9905 | €463,062 | €391,389 | -€71,673 | -15.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.